V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330008087 | 330004877 | 1.73 | 43.8 | Palliative (P) | 2016-05-24 | 2016-07-03 | CARBOPLATIN + FLUOROURACIL | 02 | N | 330014546 | CARBO + FLUOROURACIL |
| 330008088 | 330004878 | 0 | 41.9 | Curative (C) | 2015-02-11 | 2015-02-11 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330014573 | BENDAMUSTINE + RITUXIMAB |
| 330008090 | 330008665 | 1.87 | 77 | Palliative (P) | 2015-06-20 | 2015-06-21 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330014583 | CARBOPLATIN + PACLITAXEL |
| 330008091 | 330004880 | 1.6 | 55.7 | Palliative (P) | 2017-08-14 | 2017-08-28 | Carbo F | 02 | Y | 330014640 | CARBO + FLUOROURACIL |
| 330008092 | 330004881 | 1.75 | 77.8 | Palliative (P) | 2013-08-07 | 2013-08-07 | Carboplatin + Etoposide IV 3 day | 2 | null | 330014640 | CARBOPLATIN + ETOPOSIDE |
| 330008093 | 330010697 | 1.65 | 107 | Palliative (P) | 2013-09-10 | 2014-04-29 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330014643 | CARBOPLATIN + PACLITAXEL |
| 330008094 | 330010697 | null | 60 | Palliative (P) | 2017-10-27 | 2017-10-27 | Paclitaxel (2 or 3 weekly) | 2 | N | 330014643 | PACLITAXEL |
| 330008095 | 330004883 | 1.64 | 65.6 | null | 2014-05-19 | 2014-05-20 | Paclitaxel 7 day | Y | N | 330014648 | PACLITAXEL |
| 330008097 | 330008669 | 1.78 | 67.7 | Palliative (P) | 2017-09-07 | 2017-10-02 | Paclitaxel (2 or 3 weekly) | N | N | 330014687 | PACLITAXEL |
| 330008100 | 330004888 | 1.05 | 69.9 | Palliative (P) | 2015-12-14 | 2015-12-14 | CARBOPLATIN + FLUOROURACIL | N | N | 330014715 | CARBO + FLUOROURACIL |
| 330008101 | 330004890 | 0 | 76.1 | Palliative (P) | 2016-06-02 | 2016-06-20 | CNS GCT II Germinoma - Carbo Etop | 02 | N | 330014727 | CARBOPLATIN + ETOPOSIDE |
| 330008102 | 330004891 | 1.77 | 89 | Curative (C) | 2015-06-08 | 2015-06-09 | Bendamustine+Rituximab(Sub Courses) | N | N | 330014735 | BENDAMUSTINE + RITUXIMAB |
| 330008103 | 330004892 | null | null | Curative (C) | 2013-07-09 | 2013-07-29 | VAI (Ifos 3g/m2) | 02 | null | 330014736 | VAI |
| 330008104 | 330004892 | 1.58 | 75.7 | Neo-adjuvant (N) | null | 2013-11-01 | BENDAMUSTINE + RITUXIMAB | N | N | 330014736 | BENDAMUSTINE + RITUXIMAB |
| 330008105 | 330004892 | null | 66 | Curative (C) | 2014-02-21 | 2014-02-21 | EURAMOS TRIAL | 02 | null | 330014736 | EURAMOS TRIAL |
| 330008106 | 330004892 | null | 72 | null | 2014-05-27 | 2014-10-24 | ALL UKALL2011 Maintenance C1 | null | null | 330014736 | UKALL2011 |
| 330008107 | 330004894 | null | 73.5 | Palliative (P) | 2013-07-21 | 2014-04-17 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330014753 | CARBO + FLUOROURACIL |
| 330008109 | 330004897 | 1.76 | null | Palliative (P) | 2014-07-29 | 2014-09-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330014769 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330008110 | 330004898 | null | 87.9 | Palliative (P) | 2013-10-02 | 2013-10-14 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | null | 330014770 | UKALL2011 |
| 330008111 | 330004899 | 1.71 | 69.9 | Curative (C) | 2016-05-03 | 2016-09-18 | CARBOPLATIN + RT | N | N | 330014770 | CARBOPLATIN + RT |
| 330008112 | 330010705 | null | 67.1 | null | 2015-01-25 | 2015-01-25 | BENDAMUSTINE + RITUXIMAB | 2 | null | 330014785 | BENDAMUSTINE + RITUXIMAB |
| 330008113 | 330004902 | 1.51 | 72 | Palliative (P) | 2017-07-12 | 2017-07-13 | Cetuximab + Radiotherapy Maint | N | N | 330014817 | CETUXIMAB + RT |
| 330008114 | 330004902 | 1.61 | 52.9 | Curative (C) | 2017-03-29 | 2017-04-05 | VAI (Ifos 3g/m2) | N | N | 330014817 | VAI |
| 330008115 | 330011833 | 1.65 | null | Disease modification (D) | 2015-07-20 | 2015-07-20 | Bendamustine+Rituximab(Sub Courses) | N | N | 330014843 | BENDAMUSTINE + RITUXIMAB |
| 330008116 | 330004903 | 1.56 | 38.4 | Palliative (P) | 2017-07-05 | 2017-07-05 | Paclitaxel (2 or 3 weekly) | 2 | null | 330014843 | PACLITAXEL |
| 330008117 | 330004904 | 1.77 | null | Adjuvant (A) | 2017-08-30 | 2017-09-07 | VAI (Ifos 3g/m2) | N | N | 330014844 | VAI |
| 330008119 | 330004907 | 1.57 | 64.8 | Curative (C) | null | 2015-12-22 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 330014861 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330008121 | 330004908 | 1.59 | 80.1 | Adjuvant (A) | 2015-06-23 | 2015-06-26 | CETUXIMAB + RT | N | N | 330014870 | CETUXIMAB + RT |
| 330008122 | 330004909 | 1.8 | 62 | Curative (C) | 2015-01-05 | 2015-01-05 | VAI (Ifos 3g/m2) | 02 | N | 330014877 | VAI |
| 330008123 | 330004912 | 1.73 | 47.5 | Neo-adjuvant (N) | 2013-12-06 | 2013-12-07 | Carbo F | N | N | 330014884 | CARBO + FLUOROURACIL |
| 330008124 | 330010712 | 1.6 | 97.5 | Palliative (P) | null | 2013-08-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330014897 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330008125 | 330004916 | null | 87.6 | null | 2014-11-19 | 2014-12-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330014905 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330008126 | 330004917 | 1.74 | 53 | Palliative (P) | 2013-12-15 | 2013-12-18 | Cetuximab + Radiotherapy Maint | N | N | 330014906 | CETUXIMAB + RT |
| 330008127 | 330008689 | null | 82 | Palliative (P) | 2015-11-21 | 2016-05-05 | CARBOPLATIN + PACLITAXEL | N | null | 330014923 | CARBOPLATIN + PACLITAXEL |
| 330008128 | 330004919 | 1.7 | 104.65 | Curative (C) | 2015-01-02 | 2015-04-01 | VAI (Ifos 3g/m2) | N | N | 330014923 | VAI |
| 330008129 | 330004921 | null | 69.9 | null | 2014-06-25 | 2014-06-25 | CARBOPLATIN + RT | N | null | 330014936 | CARBOPLATIN + RT |
| 330008130 | 330004922 | null | 71.8 | Curative (C) | null | 2015-05-14 | Cetuximab + Radiotherapy Maint | null | null | 330014950 | CETUXIMAB + RT |
| 330008131 | 330004923 | 1.69 | null | Palliative (P) | null | 2015-04-08 | VAI (Ifos 3g/m2) | Y | null | 330014951 | VAI |
| 330008132 | 330004924 | 1.86 | null | Curative (C) | 2015-05-26 | 2015-05-26 | ALL UKALL2011 Maintenance A1 | null | N | 330014953 | UKALL2011 |
| 330008133 | 330004925 | 1.57 | 97.5 | Neo-adjuvant (N) | 2016-09-06 | 2017-06-01 | CARBOPLATIN + RT | 02 | N | 330014953 | CARBOPLATIN + RT |
| 330008134 | 330004926 | null | 64.8 | Not known (9) | 2012-10-15 | 2013-05-19 | CETUXIMAB + RT | N | N | 330014968 | CETUXIMAB + RT |
| 330008135 | 330004927 | null | 62.1 | Adjuvant (A) | null | 2014-08-07 | Cetuximab + Radiotherapy Maint | null | null | 330014973 | CETUXIMAB + RT |
| 330008136 | 330004927 | 1.83 | 94 | Palliative (P) | 2014-04-25 | 2014-09-14 | Carboplatin + Paclitaxel (weekly) | N | N | 330014973 | CARBOPLATIN + PACLITAXEL |
| 330008139 | 330004933 | 1.63 | 63.1 | Palliative (P) | null | 2013-12-16 | CARBOPLATIN + PACLITAXEL | N | N | 330015043 | CARBOPLATIN + PACLITAXEL |
| 330008140 | 330004934 | 1.75 | null | Palliative (P) | 2014-05-11 | 2014-05-24 | Paclitaxel (2 or 3 weekly) | N | N | 330015061 | PACLITAXEL |
| 330008141 | 330004935 | 1.85 | 100.7 | Curative (C) | null | 2015-12-09 | Vinblastine | 02 | N | 330015068 | VINBLASTINE |
| 330008143 | 330008697 | 1.8 | 71.3 | Neo-adjuvant (N) | 2016-07-30 | 2016-08-15 | EURO-EWING | 02 | null | 330015072 | EURO-EWING |
| 330008144 | 330008697 | 0 | 66.4 | Palliative (P) | 2016-02-18 | 2016-02-18 | Trabectedin | 02 | null | 330015072 | TRABECTEDIN |
| 330008145 | 330011836 | 1.78 | 113 | Curative (C) | null | 2017-02-24 | TEMOZOLOMIDE | null | null | 330015089 | TEMOZOLOMIDE |
| 330008146 | 330011836 | 1.68 | 57.8 | Curative (C) | 2015-08-23 | 2016-02-29 | Methotrexate intrathecal | 02 | N | 330015089 | METHOTREXATE INTRATHECAL |